I read the shares were issued to "Investors who are exempt from receiving a disclosure document" (google this term and see what you find?). So yeah, they are effectively 'on market' but in the hands of the above Investors.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
